Nanjing, China

Xiaohong He

This inventor holds 3 USPTO granted patents and 5 published patent applications. Top assignee: Bioheng Therapeutics Limited. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaohong He. Retrieved from https://idiyas.com/inventor/xiaohong-he-b5y0buk9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 7.6

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Xiaohong He

Introduction

Xiaohong He is a notable inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. His work is instrumental in advancing therapeutic options for various diseases.

Latest Patents

Xiaohong He holds a patent for a "CD7-TARGETING HUMANIZED ANTIBODY AND USE THEREOF." This innovation showcases his expertise in creating targeted therapies that can improve treatment outcomes for patients.

Career Highlights

He is currently employed at Bioheng Therapeutics Limited, where he continues to push the boundaries of medical research and development. His role at the company allows him to collaborate with other talented professionals in the field.

Collaborations

Xiaohong He works alongside Xiaoyan Jiang, who is also a key contributor to their projects. Their partnership exemplifies the collaborative spirit that drives innovation in the biotechnology sector.

Conclusion

Xiaohong He's contributions to biotechnology, particularly through his patent and work at Bioheng Therapeutics Limited, highlight his role as a significant inventor in the field. His ongoing efforts are likely to lead to further advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…